+29.1%
MRNA vs HDB
-31.0%
+60.1%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | HDB | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.7% | -1.1% | +1.8% | +1.2% |
| 7D | -8.2% | -6.2% | -2.0% | -5.8% |
| 30D | +125.6% | -6.2% | +131.8% | +131.4% |
| 3M | +197.1% | -5.9% | +202.9% | +204.7% |
| 6M | +148.5% | -25.9% | +174.4% | +176.1% |
| YTD | +363.3% | -40.2% | +403.5% | +453.9% |
| 1Y | +462.0% | -38.0% | +500.0% | +561.0% |
| All | +29.1% | -31.0% | +60.1% | +47.4% |
Cumulative growth
Daily Returns
Daily percentage return beside HDB.
Daily Out/Under-Performance
Portfolio return minus HDB return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × HDB return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded HDB wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling